3C-E

3C-E is a psychedelic phenethylamine of the 3C family. It was first synthesized by Alexander Shulgin.

History

3C-E was first synthesized and documented by Alexander Shulgin. In his book PiHKAL, Shulgin lists the dosage as 30-60 mg and the duration as 8-12 hours. He describes 3C-E as a compound with a range of effects from stimulant to psychedelic.

Chemistry

3C-E is a phenethylamine and amphetamine derivative. It is structurally related to mescaline, 2C-E, and other drugs in the 3C family. The full chemical name of 3C-E is 1-(4-ethylthio-2,5-dimethoxyphenyl)propan-2-amine.

Pharmacology

The pharmacology of 3C-E is not well-studied. However, it is believed to act as a 5-HT2A receptor agonist, similar to other psychedelic phenethylamines. This action at the 5-HT2A receptor is thought to be responsible for its psychedelic effects.

Effects

The effects of 3C-E can vary greatly depending on the dose and individual's physiology. Effects can range from stimulation and euphoria at lower doses to intense visual hallucinations and psychedelic experiences at higher doses. Other effects can include increased heart rate, increased blood pressure, dilated pupils, and feelings of empathy and love.

Legal status

The legal status of 3C-E varies by country. In the United States, it is not specifically listed as a controlled substance, but it could potentially be considered an analog of a controlled substance under the Federal Analogue Act.

See also

• 2C-E
• 3C-P
• Phenethylamine
• Psychedelic drug

3C-E Resources
Latest articles Most recent articles Ongoing trials	Wikipedia